Transfusion-Related Acute Lung Injury
Authors:
- Pearl ToyPTPearl Toy
- Ognjen GajicOGOgnjen Gajic
- 1 December 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 99 (6) , 1623-1624
Abstract
Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related mortality. It is characterized by injury to the alveolar-capillary membrane precipitated by transfusion factors, antibodies, and/or inflammatory mediators, in a susceptible host. In the absence of a specific test, TRALI is defined clinically as a syndrome of acute lung injury that develops during or within 6 h of transfusion. The absence of left atrial hypertension and large protein content of edema fluid may help differentiate TRALI from hydrostatic pulmonary edema. The treatment is supportive. The blood bank needs to be notified promptly so that an appropriate workup and prevention are initiated in a timely manner.Keywords
This publication has 8 references indexed in Scilit:
- Transfusion-related acute lung injuryTransfusion Medicine Reviews, 2003
- Single hospital experience of TRALITransfusion, 2003
- TRALI: correlation of antigen‐antibody and monocyte activation in donor‐recipient pairsTransfusion, 2003
- Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factorsBlood, 2003
- The American-European Consensus Conference On Ards. Definitions, Mechanisms, Relevant Outcomes, And Clinical Trial CoordinationAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Diagnostic and pathogenetic considerations in transfusion‐related acute lung injuryTransfusion, 1985
- SEVERE PULMONARY HYPERSENSITIVITY ASSOCIATED WITH PASSIVE TRANSFUSION OF A NEUTROPHIL-SPECIFIC ANTIBODYThe Lancet, 1984
- The value of edema fluid protein measurement in patients with pulmonary edemaThe American Journal of Medicine, 1979